Full text is available at the source.
Abstract
Patients with type 2 diabetes mellitus who survive myocardial infarction remain at high risk for recurrent cardiovascular events.
- Survivors of myocardial infarction with type 2 diabetes have a notably high risk of heart failure.
- Glucagon-like peptide-1 receptor agonists are associated with reduced cardiovascular events in patients with stable atherosclerotic disease.
- The effects of glucagon-like peptide-1 receptor agonists on patients with established myocardial infarction have not been fully evaluated.
Simplified